Presentation Features Labcorp’s Combined Oncology Diagnostic and Drug Development Platform for Clinicians and Biopharmaceutical CompaniesBURLINGTON, N.C. (BUSINESS WIRE) Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the vir.
What You Must Know About APAC Before Deploying Your Next Clinical Trial
By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical
Right now, no place in the world is a hotter spot to conduct clinical trials that the Asian-Pacific region (APAC). This popularity of the region is not new. In 2018 China was one of the hottest topics of conversation I heard at the DIA Annual Meeting. Shortly thereafter I wrote an article that featured the insights of three experts on that region. A year later the region was still attracting a lot of excitement when I produced this piece discussing how South Korea was a growing hot spot for trials. Today, the entire region remains an area of interest for clinical studies.
/PRNewswire/ OmniSeq®, an innovator in next generation sequencing in oncology, today announced the New York State Department of Health s Clinical Laboratory.
This Could Be One of the Best Ways to Treat Mental Health Issues for Millions
Over the last 20 years, “The number of psychopharmacological drugs research programs in larger drug firms has shrunk by 70% in the past decade,” reported The Guardian. “In general the larger companies have walked away from psychiatry. There are a few companies who have maintained efforts in the area but 70% tells you it’s been a pretty remarkable departure. Many withdrew from neuroscience entirely.” Of course, that needs to change, which is why companies like Silo Wellness (CSE:SILO),
Tryp Therapeutics Inc. (CSE:TRYP),
Field Trip Health Ltd. (CSE:FTRP)(OTC:FTRPF), and